Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on allogenic platelet-rich plasma for diabetic foot ulcer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • allogenic platelet-rich plasma

Snippet

Sponsor: Hanan Jafar | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: UNKNOWN